jefferies' michael yee expects amgen's horizon therapeutics deal will go through despite ftc block
Published 1 year ago • 2.6K plays • Length 4:31Download video MP4
Download video MP3
Similar videos
-
1:15
ftc sues to block amgen acquisition of horizon therapeutics
-
1:21
ftc allows amgen to move forward with $27.8 billion horizon therapeutics deal
-
3:33
jefferies' michael yee still likes amgen in the biotech sector
-
3:03
ftc suspends challenge to amgen-horizon therapeutics deal
-
3:01
ftc to challenge amgen's $28 billion deal with horizon therapeutics: report
-
1:01:30
it happened: elon musk reveals tesla's electric jet
-
3:38
china stimulus details: timing and swiftness 'very, very critical,' says morgan stanley
-
12:08
mark zuckerberg on the future of ai, his programming days, and orion ar
-
1:13
horizon therapeutics in early takeover talks
-
3:20
jefferies' michael yee expects big opportunities for a.i. in the biotech sector
-
4:31
blocking the horizon-amgen deal will be worse for pharma than for biotech, says mizuho's jared holz
-
1:21
amgen to buy horizon therapeutics for $116.50 per share
-
2:47
ftc sues to block amgen's $27.8 billion deal to acquire horizon therapeutics
-
2:57
horizon therapeutics in preliminary sale talks with amgen, sanofi, j&j
-
1:16
cramer’s stop trading: amgen
-
2:05
ftc moves to block amgen's $27.8 billion deal for horizon therapeutics: report | world dna | wion
-
1:25
amgen set to acquire horizon therapeutics in $26.4 billion deal
-
4:30
ge vernova: here's why jefferies' julien dumoulin-smith is bullish on the stock
-
2:14
expecting rising interest rates in japan in the next quarters: mashreq capital
-
3:44
ftc to challenge amgen-horizon $28b deal (hznp crashes!)
-
5:00
jefferies michael yee explains why he is bullish on biotech in 2022
-
6:23
meta has more innovation momentum than apple, says deepwater's gene munster